Dyne Therapeutics Inc (DYN)

14.52 +0.34  +2.43% NASDAQ Oct 19, 12:04 USD

Dyne Therapeutics Cash from Financing (TTM):

526.06M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 526.06M
March 31, 2021 526.03M
Dec. 31, 2020 380.69M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Veracyte Inc 793.36M
Moderna Inc 76.19M
BridgeBio Pharma Inc 553.83M

Cash from Financing (TTM) Range, Past 5 Years

Minimum 380.69M Dec 2020
Maximum 526.06M Jun 2021
Average 477.59M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.